Accessibility Menu
Balchem logo

Balchem

(NASDAQ) BCPC

Current Price$163.62
Market Cap$5.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1986)+81,081%
5 Year+31%
1 Year+6%
1 Month+1%
Balchem last closing stock price
MetricPriceDate
Last closeUSD 166.232026-07-16
Balchem stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.65%USD 163.532026-07-09
1 month+1.25%USD 164.172026-06-16
3 month-6.43%USD 177.662026-04-17
Year to date+8.39%USD 153.362025-12-31
1 year+5.76%USD 157.172025-07-16
3 year+29.41%USD 128.452023-07-17
5 year+31.41%USD 126.492021-07-16
Since inception+81,081.16%USD 0.201986-06-03

Balchem Financials at a Glance

Market Cap

$5.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.06B

Net Income (TTM)

$158.08M

EPS (TTM)

$4.87

P/E Ratio

34.14

Dividend

$0.96

Beta (Volatility)

0.74 (Low)

Price

$163.62

Volume

170,991

Open

$166.35

Previous Close

$163.35

Daily Range

$162.85 - $168.91

52-Week Range

$139.17 - $183.90

Estimated Earnings Date

Jul 30, 2026

BCPC News

BuyAlert-Purple.png

Balchem Stock Lands New $18 Million Investor as Firm Delivers Record $1 Billion in Sales

Jonathan PoncianoMar 4, 2026
SellAlert-Purple.png

Balchem Director Sells 8,000 Shares for $1.2 Million a Week Before a Dividend Hike

Howard SmithDec 12, 2025
nutrition tracking health wellness exercise

Why Balchem Stock Jumped Today

Howard SmithOct 21, 2025
Foolcom-Featured.png

Balchem (BCPC) Q2 EPS Jumps 16.5%

Motley Fool Markets TeamAug 1, 2025
Three colorful arrows racing straight up on a black background

Why Axon, Nucor, and Balchem Stocks Popped 10% on Friday

Rich SmithMar 15, 2020
GettyImages-1062733970

Why Watsco, Tennant, and Balchem Plunged Thursday

Daniel MillerMar 12, 2020
Supplements On a Table

Industrial Weakness Hurts Balchem's Second Quarter

Travis HoiumAug 2, 2019
Supplements on Spoons

Why Balchem Shares Plunged 11.9% Today

Travis HoiumAug 1, 2019
Page 1

BCPC: Motley Fool Moneyball Superscore

68

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Balchem

Balchem makes ingredients for human and animal food. It also produces gases for cleaning medical tools. These products help people and animals stay healthy.

What Does Balchem Make?

  • Human Nutrition & Health: Supplies powders, flavors, and nutrients for food and beverages; generated $171.6 million in net sales in Q1 2026.
  • Animal Nutrition & Health: Provides supplements and health products for livestock and pets; contributed $62.2 million in net sales in Q1 2026.
  • Specialty Products: Offers gases for medical device sterilization and plant nutrition; recorded $34.7 million in net sales in Q1 2026.

Recent Strategic Actions

  • Approved a new stock repurchase program in December 2025 to buy back up to 4 million shares.
  • Reached a settlement with the Environmental Protection Agency (EPA) and Department of Justice (DOJ) in January 2025 regarding environmental safety projects.
  • Repurchased 89,880 shares during the first quarter of 2026 at an average cost of $166 per share.

How the Company Stands Out

Balchem uses microencapsulation to protect nutrients in food and animal feed. This technology ensures ingredients stay effective until they are consumed. The company also manages a joint venture for the production of choline chloride, which is a key nutrient.

Performance for Early 2026

  • Net sales reached $270.7 million in Q1 2026, up 8.1% year-over-year.
  • Gross profit was $101.1 million in Q1 2026, up 14.6% from Q1 2025.
  • Net income hit $40.3 million in Q1 2026, up 8.7% from the same period in the previous year.
  • Operating cash flow rose to $40.1 million in Q1 2026, up 9.9% year-over-year.

The Bottom Line

Balchem has grown from a chemical provider into a specialist in nutrition and medical safety. Its focus on specialized ingredients for health markets drives its steady business performance.

AI Generated • May 20, 2026

Industry

Chemicals

Sector

Materials

Employees

1,352

CEO

Theodore L. Harris, MBA

Website

www.balchem.com

Headquarters

Montvale, NJ 07645, US

BCPC Financials

Key Financial Metrics (TTM)

Gross Margin

36.27%

Operating Margin

20.97%

Net Income Margin

14.95%

Return on Equity

12.38%

Return on Capital

15.06%

Return on Assets

9.33%

Earnings Yield

2.93%

Dividend Yield

0.58%

Payout Ratio

19.48%

Stock Overview

Market Cap

$5.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

32.13M

Volume

170.99K

Avg. Volume

231.94K

Financials (TTM)

Gross Profit

$383.55M

Operating Income

$221.72M

EBITDA

$270.65M

Operating Cash Flow

$220.16M

Capital Expenditure

-$44.18M

Free Cash Flow

$175.98M

Cash & ST Invst.

$72.87M

Total Debt

$184.71M

Balchem Performance Analysis

Balchem annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 942,358,00017.9%
20232023-12-31USD 922,439,000-2.1%
20242024-12-31USD 953,684,0003.4%
20252025-12-31USD 1,037,161,0008.8%
Balchem sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-302.0%
Q32025-09-304.7%
Q42025-12-31-1.5%
Q12026-03-312.7%
Balchem annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 3.2510.6%
20232023-12-31USD 3.352.8%
20242024-12-31USD 3.9317.4%
20252025-12-31USD 4.7520.9%
Balchem sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-303.5%
Q32025-09-306.0%
Q42025-12-31-2.4%
Q12026-03-313.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$270.71M

+8.1%

Gross Profit

$101.08M

+14.6%

Gross Margin

37.34%

N/A

Market Cap

$5.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.90M

N/A

Employees

1,368

N/A

Net Income

$40.29M

+8.7%

EBITDA

$67.23M

+8.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$72.87M

+46.0%

Total Debt

$184.71M

-11.2%

Accounts Receivable

$154.23M

+18.2%

Inventory

$146.74M

+1.3%

Long Term Debt

$181.06M

-11.3%

Short Term Debt

$3.65M

-6.9%

Return on Assets

9.33%

N/A

Return on Invested Capital

14.39%

N/A

Free Cash Flow

$33.81M

+9.4%

Operating Cash Flow

$40.06M

+9.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SSRMSSR Mining Inc.
$25.57-1.24%
PRMPerimeter Solutions, Inc.
$34.42-1.23%
EGOEldorado Gold Corporation
$27.95-0.25%
CBTCabot Corp.
$90.39-1.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
AALAmerican Airlines Group
$14.98-0.04%
INTCIntel
$95.04-0.02%
PATHUiPath
$12.15+0.01%

Questions About BCPC

What is the current price of Balchem?

Balchem is trading at $163.35 per share.

What is the 52-week range for Balchem?

Over the past 52 weeks, Balchem has traded between $139.17 and $183.90.

How much debt does Balchem have?

As of the most recent reporting period, Balchem reported total debt of $184.71M.

How much cash does Balchem have on hand?

Balchem reported $72.87M in cash and cash equivalents in its most recent financial results.

What is Balchem’s dividend yield?

Balchem currently has a dividend yield of 0.58%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services